Warning! Weight loss jabs like Ozempic linked to deadly cancer diagnosis in the year after using them [Video]

11:20 EST 23 Jan 2025, updated 11:29 EST 23 Jan 2025

Game-changing weight loss jabs relied on by millions of slimmers and diabetics could raise the risk of thyroid cancer in their first year of use, concerning new research has suggested. 

The drugs, which include Mounjaro, Ozempic and Wegovy, have ushered in a new era in the battle against obesity, helping dieters shed up to a fifth of their bodyweight.

But, American doctors — who tracked over 350,000 patients — have now discovered the injections put users at ‘significantly higher’ risk of the disease compared to three other common diabetes drugs. 

The overall risk of developing thyroid cancer over the course of six years on the jabs, however, remained ‘low’, experts said.

Scientists, who labelled the findings important, cautioned further research was necessary to confirm their findings.   

Around half a million Britons are now thought to be using the medication, which can help them lose up to 20 per cent of …